Literature DB >> 31656528

Diabetic ketoacidosis in a buck: a case report.

K Jayalakshmi1, P Selvaraj1, M Veeraselvam1, S Yogeshpriya1, M Venkatesan1.   

Abstract

BACKGROUND: Diabetic ketoacidosis (DKA) is a disorder of carbohydrate metabolism that causes frequent urination, emaciation, extreme tiredness and dehydration. There is little or no information available on DKA in male goat (buck). The present study was carried out to report a rare case of DKA in a buck. CASE DESCRIPTION: A 1.5 year old buck was presented with anorexia and cough. On physical examination of buck showed fever, dullness, poor body condition and pale conjunctival mucous membrane. FINDINGS/TREATMENT AND OUTCOME: The peripheral blood smear revealed the mixed infection of Theileria sp. and Anaplasma sp. The blood picture showed anaemia and leukocytosis. The animal was treated with buparvaquone )2.5 mg/kg( and long acting oxytetracycline (20 mg/kg). Post treatment evaluation was done 7 days after initial treatment. Animal showed mild improvement in feed intake, the body temperature becomes normal, but showed tachycardia with weak pulse. Subsequently, animal showed severe emaciation with frequent urination. Urinalysis revealed glycosuria, ketonuria and acidic urine (pH = 6.0). Serum biochemistry revealed hyperglycemia, hypoinsulinemia, increased level of fructosamine and triglycerides and confirmed spontaneous DKA. It was treated with biphasic isophane insulin (1.0 IU/kg) twice a day, regularly. The blood glucose level becomes normal after insulin therapy. Animal resumed adequate feed intake, improvement in haemoglobulin (Hb), packed cell volume (PCV), total erythrocyte count (TEC), and weight gain was observed.
CONCLUSION: This case study gains significance, due to its successful recovery after insulin treatment, but it requires lifelong insulin therapy to manage insulin dependent diabetes mellitus (IDDM) in this goat.

Entities:  

Keywords:  Diabetes mellitus; Diabetic ketoacidosis; Goat; Insulin

Year:  2019        PMID: 31656528      PMCID: PMC6811715     

Source DB:  PubMed          Journal:  Iran J Vet Res        ISSN: 2252-0589            Impact factor:   1.376


  11 in total

1.  Diabetes mellitus in a 6-month-old Charolais heifer calf.

Authors:  Zoe Clark
Journal:  Can Vet J       Date:  2003-11       Impact factor: 1.008

2.  [Diabetes mellitus type 1 in a goat].

Authors:  U Braun; B Gansohr; M Seidel; J Dumelin; B Wenger; B Schade; A Pospischil
Journal:  Schweiz Arch Tierheilkd       Date:  2008-12       Impact factor: 0.845

3.  Clinicopathologic characteristics, prevalence, and risk factors of spontaneous diabetes in sooty mangabeys (Cercocebus atys).

Authors:  Amelia C Jones; James G Herndon; Cynthia L Courtney; Lynn Collura; Joyce K Cohen
Journal:  Comp Med       Date:  2014-06       Impact factor: 0.982

Review 4.  HLA genetic heterogeneity in diabetes mellitus.

Authors:  A G Cudworth; H Festenstein
Journal:  Br Med Bull       Date:  1978-09       Impact factor: 4.291

5.  Secondary diabetes mellitus in a pygmy goat.

Authors:  T A Lutz; R Rossi; P Caplazi; P Ossent
Journal:  Vet Rec       Date:  1994-07-23       Impact factor: 2.695

6.  Type-I diabetes mellitus in a bull.

Authors:  D L Kitchen; A J Roussel
Journal:  J Am Vet Med Assoc       Date:  1990-09-15       Impact factor: 1.936

7.  Spontaneous diabetes mellitus in young cattle: histologic, immunohistochemical, and electron microscopic studies of the islets of Langerhans.

Authors:  H Taniyama; T Shirakawa; H Furuoka; S Osame; N Kitamura; K Miyazawa
Journal:  Vet Pathol       Date:  1993-01       Impact factor: 2.221

Review 8.  Definition of diabetes mellitus.

Authors:  L Stogdale
Journal:  Cornell Vet       Date:  1986-04

Review 9.  Immune and autoimmune aspects of diabetes mellitus.

Authors:  B S Handwerger; G Fernandes; D M Brown
Journal:  Hum Pathol       Date:  1980-07       Impact factor: 3.466

10.  Correlation between peripheral white blood cell counts and hyperglycemic emergencies.

Authors:  Wei Xu; Hai-feng Wu; Shao-gang Ma; Feng Bai; Wen Hu; Yue Jin; Hong Liu
Journal:  Int J Med Sci       Date:  2013-04-18       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.